MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Enhancing protein palmitoylation is protective in alpha-synuclein dependent cytotoxicity

    G. Ho, T. Imberdis, S. Nuber, U. Dettmer, D. Selkoe (Boston, MA, USA)

    Objective: To determine if enhancement of protein palmitoylation benefits alpha-synuclein (aS) dependent vesicular trafficking defects and cytotoxicity. Background: Recent studies suggest that vesicular trafficking defects…
  • 2018 International Congress

    Cortical correlates of dual-task turning with and without freezing of gait

    M. Mancini, S. Stuart (Portland, OR, USA)

    Objective: This study investigated the relationship between prefrontal cortex (PFC) activity and turning characteristics with and without a dual-task in in people with Parkinson’s disease…
  • 2018 International Congress

    Erotophonophilia and severe impulse control disorder in a patient with Parkinson’s disease

    C. vander Linden, H. Colle, D. Colle, J. Jankovic (Ghent, Belgium)

    Objective: N/A Background: Paraphilia a form of hyper sexuality is a rare complication of dopaminergic drugs used in the treatment of Parkinson's disease (PD). We…
  • 2018 International Congress

    Depression and associated factors in nondemented Chinese patients with Parkinson’s disease

    J. Zhu, L. Zhang (Nanjing, China)

    Objective: This study aimed to estimate the prevalence and identify potential risk factors influencing depression in 519 consecutive nondemented Chinese PD patients. Background: Depression is…
  • 2018 International Congress

    Assessing the Quality of Economic Evaluation of Treatment Options for Parkinson’s disease Using the Quality of Health Economic Studies (QHES) Scale

    M. Azharuddin, M. Adil, P. Ghosh, M. Sharma (New Delhi, India)

    Objective: The objective of this study was to critically appraise all the published evidences on the economic evaluation of treatment options for Parkinson’s disease. Background:…
  • 2018 International Congress

    Are the MDS-UPDRS-based composite scores clinically applicable?

    N. Kovács, A. Juhász, Z. Aschermann (Pécs, Hungary)

    Objective: Our aim is to evaluate the feasibility of various composite scores based on the Movement Disorder Society-sponsored Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) as…
  • 2018 International Congress

    Ankle proprioception and postural instability in Parkinson’s disease

    H. Teasdale, E. Preston, W. Spratford, G. Waddington (Bruce, Australia)

    Objective: To determine: 1. Is there a correlation between central and peripheral proprioception in Parkinson’s disease? 2. Does postural instability increase with lack of vision…
  • 2018 International Congress

    Linking neuroplastic effects to behavioral changes after balance training in Parkinson’s disease: a study protocol of a randomized controlled trial

    E. Franzén, H. Johansson, M. Freidle, U. Ekman, E. Schalling, A. Lebedev, M. Lövdén, S. Holmin, P. Svenningsson, M. Hagströmer (Huddinge, Sweden)

    Objective: In this randomized controlled trial, we will determine the effects of a highly challenging balance training (the HiBalance program) on balance, gait, cognition and…
  • 2018 International Congress

    PPMI driven sample size estimation for clinical trials in Parkinson’s disease

    K. Marek, J. Seibyl, C. Caspell-Garcia, C. Coffey, B. Mollenhauer, K. Kieburtz, C. Tanner, L. Chahine, A. Siderowf, T. Simuni (New Haven, CT, USA)

    Objective: To utilize clinical, imaging and CSF data from the Parkinson’s Progression Markers Initiative (PPMI) to estimate the sample size for disease modification studies in…
  • 2018 International Congress

    The relationship between family care giver number and progression speed of dementia

    Y. Liu, S.L. Yang, Y.C. Wu (Shanghai, China)

    Objective: Study the fact delays dementia progression. Background: Alzheimer’s disease is unrestored yet now. Relieving the life upset of patient and postponing the disease progression…
  • 1
  • 2
  • 3
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley